Teva acquires Emalex Biosciences for up to $900m

Apr 29, 2026 | Business, Globes

The Israeli pharmaceutical company has also announced first quarter results, which beat the analysts’ predictions.| Read More Front – Globes 

0 Comments

FREE ISRAEL DAILY EMAIL!

BREAKING NEWS

JNS